CROSSJECT (ISIN: FR0011716265; Mnémo: ALCJ), a specialty pharma company that is developing and will soon be marketing a portfolio of drug / device combinations for use in emergency situations, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback